Background: Anaemia and coagulopathy are common issues in critically ill patients. Transfusion can be lifesaving, however, is associated with potential life threatening adverse events. As an international transfusion guideline for this specific patient population is lacking, we hypothesize that a high heterogeneity in transfusion practices exists. In this pilot-study we assessed transfusion practice in a university hospital in the Netherlands and tested the feasibility of this protocol for an international multi-centre study. Methods: A prospective single centre cohort study was conducted. For seven days all consecutive non-readmitted patients to the adult Intensive Care Unit (ICU) were included and followed for 28 days. Patients were prospectively followed until ICU discharge or up to day 28. Patient outcome data was collected at day 28. Workload for this study protocol was scored in hours and missing data. Results: In total, 48 patients were included, needed in total three hours patient to include and collect all data, with 1.6% missing data showing the feasibility of the data acquisition. Six (12.5%) patients received red blood cells (RBCs), three patients (6.3%) received platelet concentrates, and two (4.2%) patients received plasma units. In total eight (16.7%) patients were transfused with one or more blood products. Median pre- and post-transfusion haemoglobin (Hb) levels were 7.6 (6.7–7.7) g/dL and 8.1 (7.6–8.7) g/dL, respectively. Conclusion: In this pilot-study we proved the feasibility of our protocol and observed in this small population a restrictive transfusion practice for all blood products.

Additional Metadata
Keywords Critically ill, Plasma, Platelets, Red blood cells, Transfusion practice
Persistent URL dx.doi.org/10.1016/j.tracli.2019.09.002, hdl.handle.net/1765/120414
Journal Transfusion Clinique et Biologique
Citation
de Bruin, S. (S.), Alders, M, van Bruggen, R, de Korte, D, Scheeren, T.W.L. (T. W.L.), Bakker, J, … Walsh, T. (T.). (2019). International point prevalence study of Intensive Care Unit transfusion practices—Pilot study in the Netherlands. Transfusion Clinique et Biologique. doi:10.1016/j.tracli.2019.09.002